nodes	percent_of_prediction	percent_of_DWPC	metapath
Saxagliptin—SLCO4C1—Methotrexate—testicular cancer	0.183	0.215	CbGbCtD
Saxagliptin—ABCC1—Dactinomycin—testicular cancer	0.133	0.157	CbGbCtD
Saxagliptin—ABCC1—Epirubicin—testicular cancer	0.0964	0.113	CbGbCtD
Saxagliptin—ABCC1—Vinblastine—testicular cancer	0.0833	0.0981	CbGbCtD
Saxagliptin—ABCC1—Etoposide—testicular cancer	0.0751	0.0884	CbGbCtD
Saxagliptin—CYP3A5—Ifosfamide—testicular cancer	0.0582	0.0686	CbGbCtD
Saxagliptin—ABCC1—Doxorubicin—testicular cancer	0.0512	0.0603	CbGbCtD
Saxagliptin—ABCC1—Methotrexate—testicular cancer	0.0496	0.0584	CbGbCtD
Saxagliptin—SLC22A8—Methotrexate—testicular cancer	0.0386	0.0454	CbGbCtD
Saxagliptin—CYP3A5—Etoposide—testicular cancer	0.0278	0.0328	CbGbCtD
Saxagliptin—CYP3A4—Ifosfamide—testicular cancer	0.0227	0.0267	CbGbCtD
Saxagliptin—CYP3A4—Vinblastine—testicular cancer	0.012	0.0142	CbGbCtD
Saxagliptin—CYP3A4—Etoposide—testicular cancer	0.0109	0.0128	CbGbCtD
Saxagliptin—DPP8—seminal vesicle—testicular cancer	0.0083	0.144	CbGeAlD
Saxagliptin—CYP3A4—Doxorubicin—testicular cancer	0.0074	0.00872	CbGbCtD
Saxagliptin—DPP9—female gonad—testicular cancer	0.00535	0.093	CbGeAlD
Saxagliptin—SLCO4C1—seminal vesicle—testicular cancer	0.00525	0.0912	CbGeAlD
Saxagliptin—DPP8—female gonad—testicular cancer	0.00487	0.0846	CbGeAlD
Saxagliptin—DPP9—testis—testicular cancer	0.00475	0.0825	CbGeAlD
Saxagliptin—Renal failure chronic—Ifosfamide—testicular cancer	0.00438	0.047	CcSEcCtD
Saxagliptin—DPP8—testis—testicular cancer	0.00432	0.0751	CbGeAlD
Saxagliptin—Renal failure chronic—Cisplatin—testicular cancer	0.00378	0.0406	CcSEcCtD
Saxagliptin—DPP4—embryo—testicular cancer	0.00371	0.0645	CbGeAlD
Saxagliptin—Lymphopenia—Chlorambucil—testicular cancer	0.00349	0.0374	CcSEcCtD
Saxagliptin—DPP4—seminal vesicle—testicular cancer	0.00349	0.0605	CbGeAlD
Saxagliptin—DPP9—lymph node—testicular cancer	0.00344	0.0598	CbGeAlD
Saxagliptin—Immunodeficiency—Methotrexate—testicular cancer	0.00322	0.0346	CcSEcCtD
Saxagliptin—DPP8—lymph node—testicular cancer	0.00313	0.0544	CbGeAlD
Saxagliptin—DPP4—female gonad—testicular cancer	0.00205	0.0356	CbGeAlD
Saxagliptin—ABCC1—seminal vesicle—testicular cancer	0.00197	0.0342	CbGeAlD
Saxagliptin—DPP4—testis—testicular cancer	0.00182	0.0315	CbGeAlD
Saxagliptin—Opportunistic infection—Methotrexate—testicular cancer	0.00139	0.0149	CcSEcCtD
Saxagliptin—DPP4—lymph node—testicular cancer	0.00132	0.0229	CbGeAlD
Saxagliptin—Opportunistic infection—Epirubicin—testicular cancer	0.0013	0.0139	CcSEcCtD
Saxagliptin—Infection—Carboplatin—testicular cancer	0.00123	0.0132	CcSEcCtD
Saxagliptin—Opportunistic infection—Doxorubicin—testicular cancer	0.0012	0.0129	CcSEcCtD
Saxagliptin—ABCC1—female gonad—testicular cancer	0.00116	0.0201	CbGeAlD
Saxagliptin—ABCC1—testis—testicular cancer	0.00103	0.0178	CbGeAlD
Saxagliptin—Lymphopenia—Epirubicin—testicular cancer	0.00102	0.011	CcSEcCtD
Saxagliptin—Fracture—Methotrexate—testicular cancer	0.000961	0.0103	CcSEcCtD
Saxagliptin—Multiple fractures—Methotrexate—testicular cancer	0.000961	0.0103	CcSEcCtD
Saxagliptin—Lymphopenia—Doxorubicin—testicular cancer	0.000945	0.0101	CcSEcCtD
Saxagliptin—CYP3A5—female gonad—testicular cancer	0.000889	0.0154	CbGeAlD
Saxagliptin—Blood creatinine increased—Ifosfamide—testicular cancer	0.000803	0.00861	CcSEcCtD
Saxagliptin—ABCC1—lymph node—testicular cancer	0.000744	0.0129	CbGeAlD
Saxagliptin—Pancreatitis—Ifosfamide—testicular cancer	0.000726	0.00779	CcSEcCtD
Saxagliptin—Face oedema—Cisplatin—testicular cancer	0.000713	0.00765	CcSEcCtD
Saxagliptin—Angioedema—Chlorambucil—testicular cancer	0.000713	0.00765	CcSEcCtD
Saxagliptin—Blood creatinine increased—Cisplatin—testicular cancer	0.000692	0.00743	CcSEcCtD
Saxagliptin—Nasopharyngitis—Cisplatin—testicular cancer	0.00066	0.00709	CcSEcCtD
Saxagliptin—Infestation NOS—Ifosfamide—testicular cancer	0.00066	0.00709	CcSEcCtD
Saxagliptin—Infestation—Ifosfamide—testicular cancer	0.00066	0.00709	CcSEcCtD
Saxagliptin—Infection—Chlorambucil—testicular cancer	0.000632	0.00679	CcSEcCtD
Saxagliptin—Pancreatitis—Cisplatin—testicular cancer	0.000626	0.00672	CcSEcCtD
Saxagliptin—Thrombocytopenia—Chlorambucil—testicular cancer	0.000623	0.00669	CcSEcCtD
Saxagliptin—Thrombocytopenia—Vinblastine—testicular cancer	0.000571	0.00613	CcSEcCtD
Saxagliptin—Dyspepsia—Chlorambucil—testicular cancer	0.00056	0.00601	CcSEcCtD
Saxagliptin—Gastrointestinal disorder—Chlorambucil—testicular cancer	0.00055	0.0059	CcSEcCtD
Saxagliptin—Fatigue—Chlorambucil—testicular cancer	0.000549	0.00589	CcSEcCtD
Saxagliptin—Immune system disorder—Ifosfamide—testicular cancer	0.000535	0.00575	CcSEcCtD
Saxagliptin—Infestation NOS—Etoposide—testicular cancer	0.000521	0.0056	CcSEcCtD
Saxagliptin—Infestation—Etoposide—testicular cancer	0.000521	0.0056	CcSEcCtD
Saxagliptin—Gastrointestinal pain—Chlorambucil—testicular cancer	0.000521	0.00559	CcSEcCtD
Saxagliptin—Malnutrition—Ifosfamide—testicular cancer	0.000516	0.00554	CcSEcCtD
Saxagliptin—Myalgia—Bleomycin—testicular cancer	0.000514	0.00552	CcSEcCtD
Saxagliptin—Urticaria—Chlorambucil—testicular cancer	0.000506	0.00543	CcSEcCtD
Saxagliptin—Abdominal pain—Chlorambucil—testicular cancer	0.000503	0.0054	CcSEcCtD
Saxagliptin—Anaphylactic shock—Bleomycin—testicular cancer	0.000493	0.00529	CcSEcCtD
Saxagliptin—Infection—Bleomycin—testicular cancer	0.000489	0.00525	CcSEcCtD
Saxagliptin—Thrombocytopenia—Bleomycin—testicular cancer	0.000482	0.00518	CcSEcCtD
Saxagliptin—Myalgia—Dactinomycin—testicular cancer	0.000479	0.00515	CcSEcCtD
Saxagliptin—Gastrointestinal pain—Vinblastine—testicular cancer	0.000477	0.00512	CcSEcCtD
Saxagliptin—Angioedema—Ifosfamide—testicular cancer	0.000471	0.00506	CcSEcCtD
Saxagliptin—Hypersensitivity—Chlorambucil—testicular cancer	0.000469	0.00503	CcSEcCtD
Saxagliptin—Immune system disorder—Cisplatin—testicular cancer	0.000462	0.00495	CcSEcCtD
Saxagliptin—Abdominal pain—Vinblastine—testicular cancer	0.000461	0.00495	CcSEcCtD
Saxagliptin—Asthenia—Chlorambucil—testicular cancer	0.000457	0.0049	CcSEcCtD
Saxagliptin—Infection—Dactinomycin—testicular cancer	0.000456	0.0049	CcSEcCtD
Saxagliptin—Pruritus—Chlorambucil—testicular cancer	0.00045	0.00483	CcSEcCtD
Saxagliptin—Thrombocytopenia—Dactinomycin—testicular cancer	0.00045	0.00483	CcSEcCtD
Saxagliptin—Musculoskeletal discomfort—Bleomycin—testicular cancer	0.000449	0.00482	CcSEcCtD
Saxagliptin—Malnutrition—Cisplatin—testicular cancer	0.000445	0.00477	CcSEcCtD
Saxagliptin—Myalgia—Ifosfamide—testicular cancer	0.000439	0.00471	CcSEcCtD
Saxagliptin—Arthralgia—Ifosfamide—testicular cancer	0.000439	0.00471	CcSEcCtD
Saxagliptin—Flatulence—Cisplatin—testicular cancer	0.000438	0.0047	CcSEcCtD
Saxagliptin—Unspecified disorder of skin and subcutaneous tissue—Ifosfamide—testicular cancer	0.000436	0.00468	CcSEcCtD
Saxagliptin—Hypersensitivity—Vinblastine—testicular cancer	0.00043	0.00461	CcSEcCtD
Saxagliptin—Immune system disorder—Etoposide—testicular cancer	0.000423	0.00454	CcSEcCtD
Saxagliptin—Anaphylactic shock—Ifosfamide—testicular cancer	0.000421	0.00452	CcSEcCtD
Saxagliptin—Musculoskeletal discomfort—Dactinomycin—testicular cancer	0.000419	0.00449	CcSEcCtD
Saxagliptin—Asthenia—Vinblastine—testicular cancer	0.000419	0.00449	CcSEcCtD
Saxagliptin—Infection—Ifosfamide—testicular cancer	0.000418	0.00449	CcSEcCtD
Saxagliptin—Thrombocytopenia—Ifosfamide—testicular cancer	0.000412	0.00443	CcSEcCtD
Saxagliptin—Skin disorder—Ifosfamide—testicular cancer	0.000409	0.00439	CcSEcCtD
Saxagliptin—Vomiting—Chlorambucil—testicular cancer	0.000405	0.00434	CcSEcCtD
Saxagliptin—Fatigue—Dactinomycin—testicular cancer	0.000396	0.00425	CcSEcCtD
Saxagliptin—Purpura—Epirubicin—testicular cancer	0.000394	0.00422	CcSEcCtD
Saxagliptin—Urticaria—Bleomycin—testicular cancer	0.000391	0.0042	CcSEcCtD
Saxagliptin—Hypoglycaemia—Epirubicin—testicular cancer	0.000389	0.00417	CcSEcCtD
Saxagliptin—Dizziness—Vinblastine—testicular cancer	0.000386	0.00414	CcSEcCtD
Saxagliptin—Musculoskeletal discomfort—Ifosfamide—testicular cancer	0.000384	0.00412	CcSEcCtD
Saxagliptin—Myalgia—Cisplatin—testicular cancer	0.000379	0.00406	CcSEcCtD
Saxagliptin—Nausea—Chlorambucil—testicular cancer	0.000378	0.00406	CcSEcCtD
Saxagliptin—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—testicular cancer	0.000376	0.00404	CcSEcCtD
Saxagliptin—Gastrointestinal pain—Dactinomycin—testicular cancer	0.000376	0.00403	CcSEcCtD
Saxagliptin—Vomiting—Vinblastine—testicular cancer	0.000371	0.00398	CcSEcCtD
Saxagliptin—Face oedema—Epirubicin—testicular cancer	0.000366	0.00393	CcSEcCtD
Saxagliptin—Headache—Vinblastine—testicular cancer	0.000365	0.00392	CcSEcCtD
Saxagliptin—Purpura—Doxorubicin—testicular cancer	0.000364	0.00391	CcSEcCtD
Saxagliptin—Gastrointestinal disorder—Ifosfamide—testicular cancer	0.000364	0.0039	CcSEcCtD
Saxagliptin—Abdominal pain—Dactinomycin—testicular cancer	0.000363	0.0039	CcSEcCtD
Saxagliptin—Fatigue—Ifosfamide—testicular cancer	0.000363	0.0039	CcSEcCtD
Saxagliptin—Anaphylactic shock—Cisplatin—testicular cancer	0.000363	0.0039	CcSEcCtD
Saxagliptin—Hypersensitivity—Bleomycin—testicular cancer	0.000363	0.0039	CcSEcCtD
Saxagliptin—Infection—Cisplatin—testicular cancer	0.000361	0.00387	CcSEcCtD
Saxagliptin—Hypoglycaemia—Doxorubicin—testicular cancer	0.00036	0.00386	CcSEcCtD
Saxagliptin—Thrombocytopenia—Cisplatin—testicular cancer	0.000355	0.00382	CcSEcCtD
Saxagliptin—Blood creatinine increased—Epirubicin—testicular cancer	0.000355	0.00381	CcSEcCtD
Saxagliptin—Asthenia—Bleomycin—testicular cancer	0.000353	0.00379	CcSEcCtD
Saxagliptin—Skin disorder—Cisplatin—testicular cancer	0.000353	0.00378	CcSEcCtD
Saxagliptin—Pruritus—Bleomycin—testicular cancer	0.000349	0.00374	CcSEcCtD
Saxagliptin—Nausea—Vinblastine—testicular cancer	0.000346	0.00372	CcSEcCtD
Saxagliptin—Unspecified disorder of skin and subcutaneous tissue—Etoposide—testicular cancer	0.000345	0.0037	CcSEcCtD
Saxagliptin—Gastrointestinal pain—Ifosfamide—testicular cancer	0.000344	0.0037	CcSEcCtD
Saxagliptin—Pancreatitis—Methotrexate—testicular cancer	0.000343	0.00369	CcSEcCtD
Saxagliptin—Nasopharyngitis—Epirubicin—testicular cancer	0.000339	0.00364	CcSEcCtD
Saxagliptin—Face oedema—Doxorubicin—testicular cancer	0.000339	0.00364	CcSEcCtD
Saxagliptin—Hypersensitivity—Dactinomycin—testicular cancer	0.000339	0.00363	CcSEcCtD
Saxagliptin—Gastritis—Epirubicin—testicular cancer	0.000336	0.0036	CcSEcCtD
Saxagliptin—Urticaria—Ifosfamide—testicular cancer	0.000335	0.00359	CcSEcCtD
Saxagliptin—Abdominal pain—Ifosfamide—testicular cancer	0.000333	0.00357	CcSEcCtD
Saxagliptin—Anaphylactic shock—Etoposide—testicular cancer	0.000333	0.00357	CcSEcCtD
Saxagliptin—Musculoskeletal discomfort—Cisplatin—testicular cancer	0.000331	0.00355	CcSEcCtD
Saxagliptin—Infection—Etoposide—testicular cancer	0.00033	0.00355	CcSEcCtD
Saxagliptin—Asthenia—Dactinomycin—testicular cancer	0.00033	0.00354	CcSEcCtD
Saxagliptin—Blood creatinine increased—Doxorubicin—testicular cancer	0.000329	0.00353	CcSEcCtD
Saxagliptin—Thrombocytopenia—Etoposide—testicular cancer	0.000326	0.0035	CcSEcCtD
Saxagliptin—Upper respiratory tract infection—Methotrexate—testicular cancer	0.000326	0.00349	CcSEcCtD
Saxagliptin—Skin disorder—Etoposide—testicular cancer	0.000323	0.00347	CcSEcCtD
Saxagliptin—Erectile dysfunction—Methotrexate—testicular cancer	0.000323	0.00346	CcSEcCtD
Saxagliptin—Pancreatitis—Epirubicin—testicular cancer	0.000321	0.00345	CcSEcCtD
Saxagliptin—Nasopharyngitis—Doxorubicin—testicular cancer	0.000314	0.00337	CcSEcCtD
Saxagliptin—Gastrointestinal disorder—Cisplatin—testicular cancer	0.000313	0.00336	CcSEcCtD
Saxagliptin—Vomiting—Bleomycin—testicular cancer	0.000313	0.00336	CcSEcCtD
Saxagliptin—Infestation NOS—Methotrexate—testicular cancer	0.000312	0.00335	CcSEcCtD
Saxagliptin—Infestation—Methotrexate—testicular cancer	0.000312	0.00335	CcSEcCtD
Saxagliptin—Rash—Bleomycin—testicular cancer	0.000311	0.00333	CcSEcCtD
Saxagliptin—Gastritis—Doxorubicin—testicular cancer	0.000311	0.00333	CcSEcCtD
Saxagliptin—Dermatitis—Bleomycin—testicular cancer	0.00031	0.00333	CcSEcCtD
Saxagliptin—Hypersensitivity—Ifosfamide—testicular cancer	0.00031	0.00333	CcSEcCtD
Saxagliptin—Upper respiratory tract infection—Epirubicin—testicular cancer	0.000305	0.00327	CcSEcCtD
Saxagliptin—Asthenia—Ifosfamide—testicular cancer	0.000302	0.00324	CcSEcCtD
Saxagliptin—Pruritus—Ifosfamide—testicular cancer	0.000298	0.0032	CcSEcCtD
Saxagliptin—Pancreatitis—Doxorubicin—testicular cancer	0.000297	0.00319	CcSEcCtD
Saxagliptin—Nausea—Bleomycin—testicular cancer	0.000293	0.00314	CcSEcCtD
Saxagliptin—Infestation NOS—Epirubicin—testicular cancer	0.000292	0.00314	CcSEcCtD
Saxagliptin—Infestation—Epirubicin—testicular cancer	0.000292	0.00314	CcSEcCtD
Saxagliptin—Vomiting—Dactinomycin—testicular cancer	0.000292	0.00314	CcSEcCtD
Saxagliptin—Rash—Dactinomycin—testicular cancer	0.00029	0.00311	CcSEcCtD
Saxagliptin—Gastrointestinal disorder—Etoposide—testicular cancer	0.000287	0.00308	CcSEcCtD
Saxagliptin—Fatigue—Etoposide—testicular cancer	0.000287	0.00308	CcSEcCtD
Saxagliptin—Urinary tract infection—Epirubicin—testicular cancer	0.000284	0.00305	CcSEcCtD
Saxagliptin—Upper respiratory tract infection—Doxorubicin—testicular cancer	0.000282	0.00303	CcSEcCtD
Saxagliptin—Dizziness—Ifosfamide—testicular cancer	0.000278	0.00299	CcSEcCtD
Saxagliptin—Sinusitis—Epirubicin—testicular cancer	0.000274	0.00294	CcSEcCtD
Saxagliptin—Nausea—Dactinomycin—testicular cancer	0.000273	0.00293	CcSEcCtD
Saxagliptin—Gastrointestinal pain—Etoposide—testicular cancer	0.000272	0.00292	CcSEcCtD
Saxagliptin—Infestation NOS—Doxorubicin—testicular cancer	0.00027	0.0029	CcSEcCtD
Saxagliptin—Infestation—Doxorubicin—testicular cancer	0.00027	0.0029	CcSEcCtD
Saxagliptin—Vomiting—Ifosfamide—testicular cancer	0.000268	0.00287	CcSEcCtD
Saxagliptin—Hypersensitivity—Cisplatin—testicular cancer	0.000267	0.00287	CcSEcCtD
Saxagliptin—Rash—Ifosfamide—testicular cancer	0.000265	0.00285	CcSEcCtD
Saxagliptin—Dermatitis—Ifosfamide—testicular cancer	0.000265	0.00285	CcSEcCtD
Saxagliptin—Urticaria—Etoposide—testicular cancer	0.000264	0.00284	CcSEcCtD
Saxagliptin—Abdominal pain—Etoposide—testicular cancer	0.000263	0.00282	CcSEcCtD
Saxagliptin—Urinary tract infection—Doxorubicin—testicular cancer	0.000263	0.00282	CcSEcCtD
Saxagliptin—Asthenia—Cisplatin—testicular cancer	0.00026	0.0028	CcSEcCtD
Saxagliptin—Oedema peripheral—Epirubicin—testicular cancer	0.000258	0.00277	CcSEcCtD
Saxagliptin—Sinusitis—Doxorubicin—testicular cancer	0.000254	0.00272	CcSEcCtD
Saxagliptin—Immune system disorder—Methotrexate—testicular cancer	0.000253	0.00272	CcSEcCtD
Saxagliptin—Nausea—Ifosfamide—testicular cancer	0.00025	0.00268	CcSEcCtD
Saxagliptin—Hypersensitivity—Etoposide—testicular cancer	0.000245	0.00263	CcSEcCtD
Saxagliptin—Malnutrition—Methotrexate—testicular cancer	0.000244	0.00262	CcSEcCtD
Saxagliptin—Oedema peripheral—Doxorubicin—testicular cancer	0.000239	0.00257	CcSEcCtD
Saxagliptin—Asthenia—Etoposide—testicular cancer	0.000239	0.00256	CcSEcCtD
Saxagliptin—Immune system disorder—Epirubicin—testicular cancer	0.000237	0.00254	CcSEcCtD
Saxagliptin—Pruritus—Etoposide—testicular cancer	0.000235	0.00253	CcSEcCtD
Saxagliptin—Vomiting—Cisplatin—testicular cancer	0.000231	0.00248	CcSEcCtD
Saxagliptin—Rash—Cisplatin—testicular cancer	0.000229	0.00246	CcSEcCtD
Saxagliptin—Dermatitis—Cisplatin—testicular cancer	0.000229	0.00245	CcSEcCtD
Saxagliptin—Malnutrition—Epirubicin—testicular cancer	0.000228	0.00245	CcSEcCtD
Saxagliptin—Flatulence—Epirubicin—testicular cancer	0.000225	0.00242	CcSEcCtD
Saxagliptin—Dizziness—Etoposide—testicular cancer	0.00022	0.00236	CcSEcCtD
Saxagliptin—Immune system disorder—Doxorubicin—testicular cancer	0.000219	0.00235	CcSEcCtD
Saxagliptin—Nausea—Cisplatin—testicular cancer	0.000216	0.00231	CcSEcCtD
Saxagliptin—Vomiting—Etoposide—testicular cancer	0.000211	0.00227	CcSEcCtD
Saxagliptin—Malnutrition—Doxorubicin—testicular cancer	0.000211	0.00227	CcSEcCtD
Saxagliptin—Rash—Etoposide—testicular cancer	0.00021	0.00225	CcSEcCtD
Saxagliptin—Dermatitis—Etoposide—testicular cancer	0.000209	0.00225	CcSEcCtD
Saxagliptin—Headache—Etoposide—testicular cancer	0.000208	0.00224	CcSEcCtD
Saxagliptin—Flatulence—Doxorubicin—testicular cancer	0.000208	0.00224	CcSEcCtD
Saxagliptin—Arthralgia—Methotrexate—testicular cancer	0.000208	0.00223	CcSEcCtD
Saxagliptin—Myalgia—Methotrexate—testicular cancer	0.000208	0.00223	CcSEcCtD
Saxagliptin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	0.000206	0.00222	CcSEcCtD
Saxagliptin—Anaphylactic shock—Methotrexate—testicular cancer	0.000199	0.00214	CcSEcCtD
Saxagliptin—Infection—Methotrexate—testicular cancer	0.000198	0.00212	CcSEcCtD
Saxagliptin—Nausea—Etoposide—testicular cancer	0.000198	0.00212	CcSEcCtD
Saxagliptin—Thrombocytopenia—Methotrexate—testicular cancer	0.000195	0.00209	CcSEcCtD
Saxagliptin—Arthralgia—Epirubicin—testicular cancer	0.000194	0.00209	CcSEcCtD
Saxagliptin—Myalgia—Epirubicin—testicular cancer	0.000194	0.00209	CcSEcCtD
Saxagliptin—Skin disorder—Methotrexate—testicular cancer	0.000193	0.00208	CcSEcCtD
Saxagliptin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	0.000193	0.00207	CcSEcCtD
Saxagliptin—Anaphylactic shock—Epirubicin—testicular cancer	0.000186	0.002	CcSEcCtD
Saxagliptin—Infection—Epirubicin—testicular cancer	0.000185	0.00199	CcSEcCtD
Saxagliptin—Thrombocytopenia—Epirubicin—testicular cancer	0.000183	0.00196	CcSEcCtD
Saxagliptin—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.000181	0.00195	CcSEcCtD
Saxagliptin—Skin disorder—Epirubicin—testicular cancer	0.000181	0.00194	CcSEcCtD
Saxagliptin—Arthralgia—Doxorubicin—testicular cancer	0.00018	0.00193	CcSEcCtD
Saxagliptin—Myalgia—Doxorubicin—testicular cancer	0.00018	0.00193	CcSEcCtD
Saxagliptin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	0.000179	0.00192	CcSEcCtD
Saxagliptin—Dyspepsia—Methotrexate—testicular cancer	0.000175	0.00188	CcSEcCtD
Saxagliptin—Anaphylactic shock—Doxorubicin—testicular cancer	0.000172	0.00185	CcSEcCtD
Saxagliptin—Gastrointestinal disorder—Methotrexate—testicular cancer	0.000172	0.00185	CcSEcCtD
Saxagliptin—Fatigue—Methotrexate—testicular cancer	0.000172	0.00184	CcSEcCtD
Saxagliptin—Infection—Doxorubicin—testicular cancer	0.000171	0.00184	CcSEcCtD
Saxagliptin—Musculoskeletal discomfort—Epirubicin—testicular cancer	0.00017	0.00182	CcSEcCtD
Saxagliptin—Thrombocytopenia—Doxorubicin—testicular cancer	0.000169	0.00181	CcSEcCtD
Saxagliptin—Skin disorder—Doxorubicin—testicular cancer	0.000168	0.0018	CcSEcCtD
Saxagliptin—Dyspepsia—Epirubicin—testicular cancer	0.000164	0.00176	CcSEcCtD
Saxagliptin—Gastrointestinal pain—Methotrexate—testicular cancer	0.000163	0.00175	CcSEcCtD
Saxagliptin—Gastrointestinal disorder—Epirubicin—testicular cancer	0.000161	0.00173	CcSEcCtD
Saxagliptin—Fatigue—Epirubicin—testicular cancer	0.000161	0.00173	CcSEcCtD
Saxagliptin—Urticaria—Methotrexate—testicular cancer	0.000158	0.0017	CcSEcCtD
Saxagliptin—Abdominal pain—Methotrexate—testicular cancer	0.000157	0.00169	CcSEcCtD
Saxagliptin—Musculoskeletal discomfort—Doxorubicin—testicular cancer	0.000157	0.00169	CcSEcCtD
Saxagliptin—Gastrointestinal pain—Epirubicin—testicular cancer	0.000152	0.00164	CcSEcCtD
Saxagliptin—Dyspepsia—Doxorubicin—testicular cancer	0.000152	0.00163	CcSEcCtD
Saxagliptin—Gastrointestinal disorder—Doxorubicin—testicular cancer	0.000149	0.0016	CcSEcCtD
Saxagliptin—Fatigue—Doxorubicin—testicular cancer	0.000149	0.0016	CcSEcCtD
Saxagliptin—Urticaria—Epirubicin—testicular cancer	0.000148	0.00159	CcSEcCtD
Saxagliptin—Abdominal pain—Epirubicin—testicular cancer	0.000147	0.00158	CcSEcCtD
Saxagliptin—Hypersensitivity—Methotrexate—testicular cancer	0.000147	0.00158	CcSEcCtD
Saxagliptin—Asthenia—Methotrexate—testicular cancer	0.000143	0.00153	CcSEcCtD
Saxagliptin—Gastrointestinal pain—Doxorubicin—testicular cancer	0.000141	0.00151	CcSEcCtD
Saxagliptin—Pruritus—Methotrexate—testicular cancer	0.000141	0.00151	CcSEcCtD
Saxagliptin—Hypersensitivity—Epirubicin—testicular cancer	0.000137	0.00147	CcSEcCtD
Saxagliptin—Urticaria—Doxorubicin—testicular cancer	0.000137	0.00147	CcSEcCtD
Saxagliptin—Abdominal pain—Doxorubicin—testicular cancer	0.000136	0.00146	CcSEcCtD
Saxagliptin—Asthenia—Epirubicin—testicular cancer	0.000134	0.00144	CcSEcCtD
Saxagliptin—Pruritus—Epirubicin—testicular cancer	0.000132	0.00142	CcSEcCtD
Saxagliptin—Dizziness—Methotrexate—testicular cancer	0.000132	0.00141	CcSEcCtD
Saxagliptin—Hypersensitivity—Doxorubicin—testicular cancer	0.000127	0.00136	CcSEcCtD
Saxagliptin—Vomiting—Methotrexate—testicular cancer	0.000127	0.00136	CcSEcCtD
Saxagliptin—Rash—Methotrexate—testicular cancer	0.000126	0.00135	CcSEcCtD
Saxagliptin—Dermatitis—Methotrexate—testicular cancer	0.000125	0.00135	CcSEcCtD
Saxagliptin—Headache—Methotrexate—testicular cancer	0.000125	0.00134	CcSEcCtD
Saxagliptin—Asthenia—Doxorubicin—testicular cancer	0.000124	0.00133	CcSEcCtD
Saxagliptin—Dizziness—Epirubicin—testicular cancer	0.000123	0.00132	CcSEcCtD
Saxagliptin—Pruritus—Doxorubicin—testicular cancer	0.000122	0.00131	CcSEcCtD
Saxagliptin—Vomiting—Epirubicin—testicular cancer	0.000119	0.00127	CcSEcCtD
Saxagliptin—Nausea—Methotrexate—testicular cancer	0.000118	0.00127	CcSEcCtD
Saxagliptin—Rash—Epirubicin—testicular cancer	0.000118	0.00126	CcSEcCtD
Saxagliptin—Dermatitis—Epirubicin—testicular cancer	0.000117	0.00126	CcSEcCtD
Saxagliptin—Headache—Epirubicin—testicular cancer	0.000117	0.00125	CcSEcCtD
Saxagliptin—Dizziness—Doxorubicin—testicular cancer	0.000114	0.00122	CcSEcCtD
Saxagliptin—Nausea—Epirubicin—testicular cancer	0.000111	0.00119	CcSEcCtD
Saxagliptin—Vomiting—Doxorubicin—testicular cancer	0.00011	0.00118	CcSEcCtD
Saxagliptin—Rash—Doxorubicin—testicular cancer	0.000109	0.00117	CcSEcCtD
Saxagliptin—Dermatitis—Doxorubicin—testicular cancer	0.000109	0.00117	CcSEcCtD
Saxagliptin—Headache—Doxorubicin—testicular cancer	0.000108	0.00116	CcSEcCtD
Saxagliptin—Nausea—Doxorubicin—testicular cancer	0.000102	0.0011	CcSEcCtD
